We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) SODIUM NITROPRUSSIDE INJECTION 50mg/2mL vial
Section 19A approved medicine
(Approval lapsed) SODIUM NITROPRUSSIDE INJECTION 50mg/2mL vial
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL SODIUM NITROPRUSSIDE CONCENTRATED INJECTION sodium nitroprusside 25 mg/mL concentrated injection vial - ARTG 177111
Indication(s)
Sodium Nitroprusside injection is indicated for:
- Immediate reduction of blood pressure in patients with hypertensive crises. Concomitant oral antihypertensive medication should be started while the hypertensive emergency is being brought under control with sodium nitroprusside.
- Producing controlled hypotension during anaesthesia in order to reduce bleeding in surgical procedures where surgeon and anaesthetist deem it appropriate.
- Short term therapy of cardiac failure, to enhance cardiac output and lower myocardial oxygen requirements. Patients should be commenced on oral therapy as soon as possible.